Barinthus Biotherapeutics Plc Stock Price History
BRNS Stock | 0.89 0.10 10.10% |
If you're considering investing in Barinthus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Barinthus Biotherapeutics stands at 0.89, as last reported on the 25th of November, with the highest price reaching 1.02 and the lowest price hitting 0.89 during the day. Barinthus Biotherapeutics secures Sharpe Ratio (or Efficiency) of -0.0604, which signifies that the company had a -0.0604% return per unit of risk over the last 3 months. Barinthus Biotherapeutics plc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Barinthus Biotherapeutics' Standard Deviation of 5.74, risk adjusted performance of (0.04), and Mean Deviation of 3.53 to double-check the risk estimate we provide.
At this time, Barinthus Biotherapeutics' Common Stock is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 136.9 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 0 in 2024, whereas Price To Sales Ratio is likely to drop 167.79 in 2024. Barinthus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Barinthus |
Sharpe Ratio = -0.0604
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BRNS |
Estimated Market Risk
5.76 actual daily | 51 51% of assets are less volatile |
Expected Return
-0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Barinthus Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Barinthus Biotherapeutics by adding Barinthus Biotherapeutics to a well-diversified portfolio.
Price Book 0.226 | Enterprise Value Ebitda (6.67) | Price Sales 2.4045 | Shares Float 28.2 M | Wall Street Target Price 7.1667 |
Barinthus Biotherapeutics Stock Price History Chart
There are several ways to analyze Barinthus Stock price data. The simplest method is using a basic Barinthus candlestick price chart, which shows Barinthus Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 25, 2024 | 1.49 |
Lowest Price | November 18, 2024 | 0.84 |
Barinthus Biotherapeutics November 25, 2024 Stock Price Synopsis
Various analyses of Barinthus Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Barinthus Stock. It can be used to describe the percentage change in the price of Barinthus Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Barinthus Stock.Barinthus Biotherapeutics Price Action Indicator | (0.11) | |
Barinthus Biotherapeutics Price Daily Balance Of Power | (0.77) | |
Barinthus Biotherapeutics Price Rate Of Daily Change | 0.90 |
Barinthus Biotherapeutics November 25, 2024 Stock Price Analysis
Barinthus Stock Price History Data
The price series of Barinthus Biotherapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 0.65 with a coefficient of variation of 11.5. The prices are distributed with arithmetic mean of 1.26. The median price for the last 90 days is 1.25.Open | High | Low | Close | Volume | ||
11/25/2024 | 1.02 | 1.02 | 0.89 | 0.89 | ||
11/22/2024 | 1.02 | 1.02 | 0.89 | 0.89 | 142,281 | |
11/21/2024 | 0.90 | 0.99 | 0.90 | 0.99 | 39,802 | |
11/20/2024 | 0.91 | 0.97 | 0.86 | 0.90 | 50,229 | |
11/19/2024 | 0.88 | 0.99 | 0.85 | 0.89 | 56,126 | |
11/18/2024 | 1.00 | 1.00 | 0.81 | 0.84 | 256,190 | |
11/15/2024 | 1.35 | 1.38 | 0.88 | 0.97 | 263,301 | |
11/14/2024 | 1.43 | 1.43 | 1.35 | 1.38 | 26,449 | |
11/13/2024 | 1.44 | 1.44 | 1.34 | 1.40 | 59,918 | |
11/12/2024 | 1.40 | 1.44 | 1.28 | 1.40 | 29,137 | |
11/11/2024 | 1.33 | 1.41 | 1.33 | 1.37 | 16,683 | |
11/08/2024 | 1.52 | 1.52 | 1.35 | 1.35 | 43,853 | |
11/07/2024 | 1.48 | 1.50 | 1.45 | 1.47 | 8,884 | |
11/06/2024 | 1.35 | 1.49 | 1.35 | 1.48 | 9,834 | |
11/05/2024 | 1.40 | 1.40 | 1.31 | 1.34 | 11,897 | |
11/04/2024 | 1.42 | 1.48 | 1.34 | 1.45 | 12,679 | |
11/01/2024 | 1.47 | 1.51 | 1.43 | 1.43 | 10,864 | |
10/31/2024 | 1.49 | 1.52 | 1.42 | 1.49 | 20,672 | |
10/30/2024 | 1.45 | 1.47 | 1.43 | 1.43 | 3,655 | |
10/29/2024 | 1.41 | 1.46 | 1.41 | 1.45 | 10,585 | |
10/28/2024 | 1.49 | 1.50 | 1.40 | 1.41 | 15,314 | |
10/25/2024 | 1.53 | 1.53 | 1.44 | 1.49 | 11,586 | |
10/24/2024 | 1.35 | 1.44 | 1.35 | 1.43 | 9,996 | |
10/23/2024 | 1.49 | 1.52 | 1.34 | 1.37 | 29,670 | |
10/22/2024 | 1.49 | 1.49 | 1.34 | 1.47 | 8,519 | |
10/21/2024 | 1.23 | 1.48 | 1.23 | 1.33 | 28,970 | |
10/18/2024 | 1.23 | 1.33 | 1.19 | 1.23 | 299,710 | |
10/17/2024 | 1.18 | 1.20 | 1.18 | 1.20 | 6,590 | |
10/16/2024 | 1.20 | 1.21 | 1.16 | 1.20 | 27,065 | |
10/15/2024 | 1.21 | 1.21 | 1.15 | 1.20 | 5,808 | |
10/14/2024 | 1.19 | 1.20 | 1.17 | 1.17 | 26,884 | |
10/11/2024 | 1.17 | 1.17 | 1.14 | 1.17 | 5,993 | |
10/10/2024 | 1.21 | 1.21 | 1.14 | 1.19 | 50,344 | |
10/09/2024 | 1.24 | 1.24 | 1.16 | 1.19 | 2,307 | |
10/08/2024 | 1.27 | 1.27 | 1.20 | 1.21 | 9,781 | |
10/07/2024 | 1.33 | 1.35 | 1.24 | 1.26 | 470,023 | |
10/04/2024 | 1.27 | 1.33 | 1.20 | 1.33 | 40,496 | |
10/03/2024 | 1.16 | 1.29 | 1.16 | 1.24 | 15,737 | |
10/02/2024 | 1.15 | 1.26 | 1.15 | 1.20 | 30,577 | |
10/01/2024 | 1.20 | 1.25 | 1.16 | 1.18 | 51,978 | |
09/30/2024 | 1.19 | 1.25 | 1.19 | 1.19 | 12,367 | |
09/27/2024 | 1.21 | 1.21 | 1.18 | 1.18 | 1,729 | |
09/26/2024 | 1.24 | 1.24 | 1.20 | 1.20 | 786.00 | |
09/25/2024 | 1.21 | 1.23 | 1.20 | 1.20 | 9,465 | |
09/24/2024 | 1.20 | 1.20 | 1.20 | 1.20 | 674.00 | |
09/23/2024 | 1.27 | 1.28 | 1.20 | 1.20 | 3,215 | |
09/20/2024 | 1.28 | 1.28 | 1.21 | 1.23 | 12,518 | |
09/19/2024 | 1.23 | 1.27 | 1.22 | 1.23 | 30,090 | |
09/18/2024 | 1.17 | 1.28 | 1.17 | 1.23 | 9,306 | |
09/17/2024 | 1.25 | 1.28 | 1.24 | 1.25 | 8,175 | |
09/16/2024 | 1.25 | 1.35 | 1.23 | 1.26 | 11,292 | |
09/13/2024 | 1.28 | 1.31 | 1.26 | 1.27 | 15,463 | |
09/12/2024 | 1.25 | 1.31 | 1.23 | 1.28 | 51,112 | |
09/11/2024 | 1.25 | 1.29 | 1.23 | 1.23 | 13,291 | |
09/10/2024 | 1.30 | 1.31 | 1.24 | 1.24 | 21,765 | |
09/09/2024 | 1.35 | 1.44 | 1.27 | 1.27 | 8,541 | |
09/06/2024 | 1.30 | 1.30 | 1.25 | 1.28 | 75,075 | |
09/05/2024 | 1.36 | 1.38 | 1.11 | 1.23 | 82,510 | |
09/04/2024 | 1.37 | 1.43 | 1.27 | 1.29 | 29,078 | |
09/03/2024 | 1.36 | 1.40 | 1.28 | 1.32 | 11,057 | |
08/30/2024 | 1.32 | 1.32 | 1.27 | 1.32 | 2,722 |
About Barinthus Biotherapeutics Stock history
Barinthus Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Barinthus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Barinthus Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Barinthus Biotherapeutics stock prices may prove useful in developing a viable investing in Barinthus Biotherapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 38.4 M | 32.5 M | |
Net Loss | -45.8 M | -48.1 M |
Barinthus Biotherapeutics Quarterly Net Working Capital |
|
Barinthus Biotherapeutics Stock Technical Analysis
Barinthus Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
Barinthus Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Barinthus Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Barinthus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Barinthus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.45) | |||
Total Risk Alpha | (1.25) | |||
Treynor Ratio | (0.40) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Barinthus Stock Analysis
When running Barinthus Biotherapeutics' price analysis, check to measure Barinthus Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barinthus Biotherapeutics is operating at the current time. Most of Barinthus Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Barinthus Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barinthus Biotherapeutics' price. Additionally, you may evaluate how the addition of Barinthus Biotherapeutics to your portfolios can decrease your overall portfolio volatility.